CLEARSIDE BIOMEDICAL INC's ticker is CLSD and the CUSIP is 185063104. A total of 47 filers reported holding CLEARSIDE BIOMEDICAL INC in Q3 2023. The put-call ratio across all filers is 1.66 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $15 | -59.5% | 17,536 | -48.7% | 0.00% | – |
Q2 2023 | $37 | -73.8% | 34,165 | -75.1% | 0.00% | -100.0% |
Q1 2023 | $141 | -7.2% | 137,221 | 0.0% | 0.00% | 0.0% |
Q4 2022 | $152 | -99.6% | 137,221 | +331.5% | 0.00% | – |
Q3 2022 | $35,000 | -31.4% | 31,799 | -10.0% | 0.00% | – |
Q2 2022 | $51,000 | – | 35,333 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ACT CAPITAL MANAGEMENT, LLC | 2,467,500 | $14,805,000 | 7.67% |
ACUTA CAPITAL PARTNERS, LLC | 1,316,268 | $7,898,000 | 2.79% |
AJU IB Investment Co., Ltd. | 293,555 | $1,761,000 | 1.14% |
RTW INVESTMENTS, LP | 4,206,765 | $25,241,000 | 0.38% |
EAM Investors, LLC | 247,561 | $1,485,000 | 0.25% |
Carmignac Gestion | 2,475,652 | $14,854,000 | 0.18% |
Curi Wealth Management, LLC | 25,000 | $150,000 | 0.07% |
CAXTON ASSOCIATES LP | 66,569 | $399,000 | 0.04% |
Newman Dignan & Sheerar, Inc. | 21,523 | $129,000 | 0.04% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 316,600 | $1,900,000 | 0.04% |